GlassScriptPhysician profile
Kevin Michael Hwang
NPI 1518348085
$3,832.47
in general payments reported to CMS, 2019-2025
9 companies · $505 in 2025
The $505 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $364 · 2022: $569 · 2023: $49.69 · 2024: $2,345 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,165 · Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,164.91 |
| Food and Beverage | $734.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,475.09 | 2024 | Other - Miscellaneous |
| Nuvasive, INC. | $761.68 | 2021-2023 | Simplify Cervical Artificial Disc |
| Stryker Corporation | $495.31 | 2021-2024 | T2 Alpha, Gamma, Mild Device Kit |
| Arthrex, INC. | $373.90 | 2024-2025 | |
| Evolution Surgical, INC | $368.04 | 2024 | |
| Globus Medical, INC. | $133.17 | 2025 | Alif, Reline, Mlx |
| Medtronic, INC. | $115.47 | 2022-2025 | Mazor X System, Magnifuse Bone Graft, Unid_pass |
| Intuitive Surgical, INC. | $92.31 | 2024 | |
| Carlsmed, INC. | $17.50 | 2025 | Aprevo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.